Site-specific antibody labeling with novel photocrosslinking technology
Our research presents a novel, site-specific approach to labeling antibodies with molecules for various applications, improving upon traditional methods of antibody conjugation. The method is widely compatible and modular, enabling labs to rapidly label their antibodies for improved assay performance.
Antibodies are highly-specific, Y-shaped proteins that serve as versatile tools for research, diagnostic and therapeutic applications. The two arms of the antibody are able to seek and bind cellular and molecular targets. Researchers have long harnessed the specific binding capability of antibodies for various purposes. For example, antibodies can be labeled with cargo, such as drugs or fluorescent dyes, acting as a carrier that directs the cargo to specific cell populations. While methods used to label or ‘conjugate’ antibodies have long been established, these traditional methods have limitations that impact the performance of antibodies in assays and drug delivery.
Labeling antibodies with cargo or other functional molecules can be accomplished through a variety of chemical methods that link these molecules to specific amino acids that are naturally present on the antibody surface. However, these common labeling methods are not “site-specific”, meaning that the cargo molecules are randomly attached to the antibody, including to sites near or even within the antibody’s binding region (Fig. 1). This can interfere with antibody binding to its target and results in a heterogeneous mix of antibody conjugates. The end result of non site-specific labeling is lower assay sensitivity and specificity.
Our research presents a novel approach to conjugate antibodies by using photo-reactive linker molecules that site-specifically and uniformly bind the Fc-constant region of the antibody, which vastly improves the antibody’s binding ability and performance. These small linker molecules are known as photo-reactive antibody binding domains (pAbBD) or the trade name oYo-LinkTM (AlphaThera, LLC). The pAbBDs are either expressed as a fusion protein with the desired cargo of interest or can be generated with a unique reactive chemical handle at the c-terminus that allows for the precise attachment of the desired cargo. These linker molecules, when exposed to 365 nm ‘black’ light, will covalently attach onto the Fc-region of nearly any existing, “off-the-shelf” antibody. Thus, the linker brings the cargo along and the result is an antibody labeled with the desired molecule. The entire antibody labeling procedure can be accomplished in under 2 hours with 30 seconds hands-on time (Fig. 2).
Another distinguishing feature of our method is its broad compatibility with a wide pH range and buffer conditions, which traditional non-specific chemical labeling methods cannot achieve. This reduces the need for optimization or purification and makes labeling “plug and play”. The result of this site-specific labeling method is a yield of homogeneous antibody conjugates that offer improved control and assay performance for a wide number of applications that utilize antibodies. This includes assays that require the immobilization of antibodies on surfaces, whereby site-specific labeling can ensure correct antibody orientation on these surfaces and dramatically improve assay sensitivity. We envision that photo-reactive antibody-binding domains will be widely useful in improving a diverse range of antibody applications.
Andrew Tsourkas, James Hui, Joseph Iwasyk
University of Pennsylvania, USA
LASIC: Light Activated Site-Specific Conjugation of Native IgGs
James Z Hui, Shereen Tamsen, Yang Song, Andrew Tsourkas
Bioconjug Chem. 2015 Aug 19
Leave a Reply
You must be logged in to post a comment.